The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1995
The purpose of this study is to evaluate the safety and effectiveness of epoetin alfa versus placebo in reducing the transfusion requirements in anemic patients with multiple myeloma, and to investigate the quality-of-life benefits associated with the use of epoetin alfa. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.
Epistemonikos ID: c321c9bb55169348b76c6c262ced7bd2ac02c10e
First added on: May 04, 2024